Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 40 of 144 pages ‹ First < 38 39 40 41 42 > Last ›
HSL12734
Pharmacovigilance in Europe and patient safety: no to deregulation
Medicines in Europe Forum, Health Action International Europe and International Society of Drug Bulletins 2008 Feb 1
http://www.isdbweb.org/pag/documents/PR_ConsultPharmacoVigJan08_En.pdf
HSL12750
Bate A, Lindquist M, Edwards IR.
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
Fundam Clin Pharmacol 2008 Feb 1;
http://www.ncbi.nlm.nih.gov/pubmed/18248442
HSL12776
Wipond R.
CanWest Global Attacks Drug Ad Laws
Focus 2008 Feb 1
http://robwipond.com/?p=50
HSL12884
UK Department of Health
Best practice guidance for joint working between the NHS and the pharmaceutical industry
: UK Department of Health 2008 Feb 1
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_082370
HSL13166
Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
Impact of 'off-label' utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Am J Cardiol 2008 Feb 1; 101:(3):293-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01903-0
HSL13167
Ting HH, Roe MT, Gersh BJ, Spertus JA, Rumsfeld JS, Ou FS, Kao J, Long KH, Holmes DR Jr, Peterson ED; National Cardiovascular Data Registry (NCDR).
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction.
Am J Cardiol 2008 Feb 1; 101:(3):286-92
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01901-7
HSL12581
Saginur M, Graham ID, Forster AJ, Boucher M, Wells GA.
The uptake of technologies designed to influence medication safety in Canadian hospitals.
J Eval Clin Pract 2008 Feb; 14:(1):27-35
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00780.x
HSL12582
Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC.
Prevalence and determinants of pharmacy shopping behaviour.
J Clin Pharm Ther 2008 Feb; 33:(1):17-23
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00878.x
HSL12583
Mason A.
New medicines in primary care: a review of influences on general practitioner prescribing.
J Clin Pharm Ther 2008 Feb; 33:(1):1-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00875.x
HSL12591
Siracuse MV, Vuchetich PJ.
Impact of Medicaid Prior Authorization Requirement for COX-2 Inhibitor Drugs in Nebraska.
Health Serv Res 2008 Feb; 43:(1):
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2007.00766.x
HSL12692
Cassels A.
Media mum on bad news drugs
Common Ground 2008 Feb
http://commonground.ca/iss/199/cg199_cassels.shtml
HSL12697
Is the Tipping Point Toast?
Fast Company.com 2008 Feb
http://www.fastcompany.com/magazine/122/is-the-tipping-point-toast.html
HSL12710
Pharmacovigilance in Europe and patient safety: no to deregulation
HAI 2008 Feb
www.haiweb.org/15022008/PR_ConsultPharmacoVigJan08_En.pdf
HSL12724
Barker E.
A World Without Men
Whole Life Times 2008 Feb
http://wholelifetimes.com/2008/02/healthyliving0802.html
HSL12725
Pearce N.
Corporate influences on epidemiology.
Int J Epidemiol 2008 Feb; 37:(1):46-53
http://www.ncbi.nlm.nih.gov/pubmed/18245050?dopt=Abstract
HSL12726
Haas J.
Commentary: Epidemiology and the pharmaceutical industry: an inside perspective.
Int J Epidemiol 2008 Feb; 37:(1):53-5
http://ije.oxfordjournals.org/cgi/content/extract/37/1/53
HSL12727
White A, Robinson N, Egger P, Stender M, Davis K, Weil J, Bowlin S.
Commentary: Collaboration between industry-based and academic epidemiologists.
Int J Epidemiol 2008 Feb; 37:(1):56-7
http://ije.oxfordjournals.org/cgi/content/extract/37/1/56
HSL12728
Greenland S.
Commentary: addressing corporate influence through ethical guidelines.
Int J Epidemiol 2008 Feb; 37:(1):57-9
http://ije.oxfordjournals.org/cgi/content/extract/37/1/57
HSL12729
Phillips CV.
Commentary: Lack of scientific influences on epidemiology.
Int J Epidemiol 2008 Feb; 37:(1):59-64
http://ije.oxfordjournals.org/cgi/content/extract/37/1/59
HSL12730
Pearce N.
Response: The distribution and determinants of epidemiologic research.
Int J Epidemiol 2008 Feb; 37:(1):65-8
http://ije.oxfordjournals.org/cgi/content/extract/37/1/65
HSL12787
Millard WB.
Dispatch from the pharmasphere: an industry's fault lines on display.
Ann Emerg Med 2008 Feb; 51:(2):175-80
http://www.ncbi.nlm.nih.gov/pubmed/18217227?dopt=Abstract
HSL12839
FDA
Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices
: FDA 2008 Feb
http://www.fda.gov/oc/op/goodreprint.html
HSL12848
Kaufman SR.
Bias and sponsored research.
Ophthalmology 2008 Feb; 115:(2):412-3
http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(07)00852-4
HSL12872
Siekmeier R, Lütz J, Wetzel D.
[Are test systems for diagnostics of infectious diseases safe? Experiences of the BfArM based on all notifications received until end of 2005]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008 Feb; 51:(2):221-34
http://www.springerlink.com/content/y8683g7084571486/
HSL12909
Schipper I, Weyzig F
Ethics for Drug Testing in Low and Middle Income Countries: Considerations for European Market Authorisation
Amsterdam: Stichting Onderzoek Multinationale Ondernemingen (Centre for Research on Multinational Corporations) 2008 Feb
http://www.somo.nl/html/paginas/pdf/Ethics_for_Drug_Testing_feb08_EN.pdf
HSL12948
Association of American Medical Colleges (AAMC) / Association of American Universities (AAU)
Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI policies in Human Subjects Research
: Association of American Medical Colleges (AAMC) / Association of American Universities (AAU) 2008 Feb
https://services.aamc.org/Publications/showfile.cfm?file=version107.pdf&prd_id=220&prv_id=268&pdf_id=107
HSL12949
Herxheimer A, Sanz E.
Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look back
European Journal of Clinical Pharmacology 2008 Feb; 64:(2):107-114
http://www.springerlink.com/content/u2rn52n6x15x71h6/fulltext.html
HSL13034
Hayden EC.
Battle over eye medicine gives drugmaker a dose of reality
Nat Med 2008 Feb; 14:(2):108
http://www.nature.com/doifinder/10.1038/nm0208-108
HSL13035
Hughes V.
Europe pledges billions to solve its drug development woes.
Nat Med 2008 Feb; 14:(2):107
http://www.nature.com/doifinder/10.1038/nm0208-107
HSL13380
[No authors listed]
ADA advertising standards.
J Am Dent Assoc. 2008 Feb; 139:(2):204-5
HSL13458
O'Donovan O, Glavanis-Grantham K. (Eds)
Power, Politics and Pharmaceuticals: Drug Regulation in Ireland in the Global Context
: Cork University Press 2008
http://www.corkuniversitypress.com/epages/corkuniversitypress.storefront
HSL13506
Gibson BR, Suh R, Tilson H.
The US drug safety system: role of the pharmaceutical industry.
Pharmacoepidemiol Drug Saf. 2008 Feb; 17:(2):110-4
http://www3.interscience.wiley.com/cgi-bin/abstract/115807412/ABSTRACT?CRETRY=1&SRETRY=0
HSL13543
Kahn M, Gastrow M.
Pharmacologically active: clinical trials and the pharmaceutical industry.
S Afr Med J 2008 Feb; 98:(2):114-6
HSL13682
Bruce S.
Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging.
J Drugs Dermatol 2008 Feb; 7:(2):
http://www.ncbi.nlm.nih.gov/pubmed/18404867
HSL13685
Shoenfeld Y.
[Doctors as naive (innocent) drug advertisers].
Harefuah 2008 Feb; 147:(2):98-9
http://www.ncbi.nlm.nih.gov/pubmed/18357661
HSL13750
Trabert G.
[The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].
Zentralbl Chir 2008 Feb; 133:(1):39-45
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1004667
HSL13801
Juni S, Gross JS.
Emotional and persuasive perception of fonts.
Percept Mot Skills 2008 Feb; 106:(1):35-42
http://www.ncbi.nlm.nih.gov/pubmed/18459353
HSL13838
Berg TL.
The creation of the medical consumer.
S D Med 2008 Feb; 61:(2):42
http://www.ncbi.nlm.nih.gov/pubmed/18432148
HSL14210
Demortain D.
From drug crises to regulatory change: The mediation of expertise
Health, Risk & Society 2008 Feb; 10:(1):37-51
http://www.tandf.co.uk/journals/journal.asp?issn=1369-8575&linktype=9
HSL16107
Barnard J, Lai R, Robson A
Increasing Transparency in Pharmaceutical Marketing Communications: the new code from the European Federation of Pharmaceutical Industries and Associations (EFPIA)
: KeywordPharma 2008 Feb
http://www.keywordpharma.com/selection5/
HSL12640
Fox M.
U.S. researcher admits to leaking drug data
The Guardian 2008 Jan 31
http://www.guardian.co.uk/feedarticle?id=7269595
HSL12641
Lilly may settle over anti-psychotic Zyprexa
CNN Money.com 2008 Jan 31
http://money.cnn.com/2008/01/31/news/companies/lilly_zyprexa.ap/index.htm?source=yahoo_quote
HSL12642
Imclone Swings to Loss on Legal Charge
Yahoo.com 2008 Jan 31
http://biz.yahoo.com/ap/080131/earns_imclone.html?.v=1
HSL12643
Rubenstein S.
When Drug Trials Go Wrong, Patients Have Little Recourse
The Wall Street Journal 2008 Jan 31
http://online.wsj.com/article/SB120173515260330205.html
HSL12647
Murphy T.
Shareholders Sue Lilly Over Zyprexa Woes
Yahoo Finance 2008 Jan 31
http://biz.yahoo.com/ap/080131/zyprexa_lawsuit.html?.v=2
HSL12648
Berenson A.
Lilly Considers $1 Billion Fine to Settle Case
The New York Times 2008 Jan 31
http://www.nytimes.com/2008/01/31/business/31drug.html?_r=1&oref=slogin
HSL12654
FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior with Antiepileptic Medications
FDA 2008 Jan 31
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01786.html
HSL12694
Johnson A, Carreyrou J.
Lilly Is in Talks to Settle Zyprexa Allegations
The Wall Street Journal 2008 Jan 31
http://online.wsj.com/article/SB120174903737930987.html
HSL12696
Ward G.
Vanderbilt bans most gifts from drug firms
Tennessean.com 2008 Jan 31
http://www.fairviewobserver.com/apps/pbcs.dll/article?AID=/20080131/BUSINESS01/801310366/1321/MTCN06
HSL12698
Bansal P.
Merck probed over Vioxx marketing: report
Reuters.com 2008 Jan 31
http://www.reuters.com/article/ousiv/idUSN3137171220080201
HSL12699
Lawler B.
Who Let the Docs Out?
The Motley Fool 2008 Jan 31
http://www.fool.com/investing/dividends-income/2008/01/31/who-let-the-docs-out.aspx
HSL12739
Schuettler D.
Thailand scraps patent override on Novartis drug
Reuters.com 2008 Jan 31
http://www.reuters.com/article/africaCrisis/idUSBKK24285
HSL12784
Boscoe M, Lippman A, Reynolds A, Rochon Ford A
Letter to the editor re: disinformation about HPV vaccine
: The Canadian Women's Health Network 2008 Jan 31
http://www.cwhn.ca/resources/pub/globe_letter_jan08.htm
HSL12623
Vastag B.
Reviewer leaked Avandia study to drug firm: GlaxoSmithKline told early of diabetes blockbuster's links to heart attacks.
naturenews 2008 Jan 30
http://www.nature.com/news/2008/080130/full/451509a.html
HSL12625
Berenson A.
Lilly in Settlement Talks With U.S.
The New York Times 2008 Jan 30
http://www.nytimes.com/2008/01/30/business/30cnd-drug.html?ref=business
HSL12627
Metherell M.
Drugs no longer only remedy as GPs cut scripts
The Sydney Morning Herald 2008 Jan 30
http://www.smh.com.au/news/national/drugs-no-longer-only-remedy-as-gps-cut-scripts/2008/01/29/1201369135245.html
HSL12629
Cresswell A.
Doctors rushing patients for tests
The Australian 2008 Jan 30
http://www.theaustralian.news.com.au/story/0,25197,23130168-23289,00.html
HSL12630
Goldstein J.
What’s Buried In Merck’s Earnings
The Wall Street Journal 2008 Jan 30
http://blogs.wsj.com/health/2008/01/30/whats-buried-in-mercks-earnings/?mod=yahoo_hs
HSL12631
Koroneos G.
Vytorin Scripts Plummet
PharmExec.com 2008 Jan 30
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=487084
HSL12633
Won TesorIiero H.
Trouble Brews Over Merck Product
The Wall Street Journal 2008 Jan 30
http://online.wsj.com/article/SB120165519331327133.html?mod=googlenews_wsj
HSL12635
Koroneos G.
Hold That Call: Physician Detailing Preferences Revealed
PharmExec.com 2008 Jan 30
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=487082
HSL12636
Cohen R.
FDA's health dire, experts say: Setbacks highlight an agency in crisis
The Star Ledger 2008 Jan 30
http://www.nj.com/business/ledger/index.ssf?/base/business-8/1201671376279680.xml&coll=1
HSL12637
Koroneos G.
Vermont Amends Data Mining Law
PharmExec.com 2008 Jan 30
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=487083
HSL12638
Saul S.
Doctor Accused of Leak to Drug Maker
The New York Times 2008 Jan 30
http://www.nytimes.com/2008/01/30/business/30cnd-censure.html
HSL12639
Abelson R.
Financial Ties Are Cited as Issue in Spine Study
The New York Times 2008 Jan 30
http://www.nytimes.com/2008/01/30/business/30spine.html
HSL12645
Fantasy Pharma Economics from The Atlantic
GoozNews.com 2008 Jan 30
http://www.gooznews.com/archives/000956.html
HSL12652
Publish or perish
The Ottawa Citizen 2008 Jan 30
HSL12653
Prescription rate falls 11%
Pharmacy Daily 2008 Jan 30
www.pharmacydaily.com.au (registration required)
HSL12660
Perrone M.
Drug industry rethinks trinket marketing
The York Dispatch 2008 Jan 30
http://yorkdispatch.inyork.com/yd/business/ci_8118541
HSL15069
Glaxo Warns of a Charge, Hints at Pact
The Wall Street Journal 2008 Jan 30
http://online.wsj.com/article/SB123327051846730799.html
HSL12617
Parker-Pope T.
Great Drug, but Does It Prolong Life?
The New York Times 2008 Jan 29
http://www.nytimes.com/2008/01/29/health/29well.html?_r=1&ref=science&oref=slogin
HSL12622
Perrone M.
Drug Group Says Sales Tactics Need Examining: Trinkets for doctors falling out of favor
The Day.com 2008 Jan 29
http://www.theday.com/re.aspx?re=80a0ccbd-783e-4d29-8c52-8024ec6ffe80
HSL12632
Goldstein J.
SEC Chides Bristol-Myers, Boston Scientific & Baxter on Pay
The Wall Street Journal 2008 Jan 29
http://blogs.wsj.com/health/2008/01/29/sec-chides-bristol-myers-boston-scientific-baxter/
HSL12634
Johnson A.
Lilly’s Next CEO Counterpunches for Pharma
The Wall Street Journal 2008 Jan 29
http://blogs.wsj.com/health/2008/01/29/lillys-next-ceo-counterpunches-for-pharma/
HSL12659
Ricks D.
Boom in similar drug names fuels medicine mix-ups
Newsday.com 2008 Jan 29
http://www.newsday.com/news/health/ny-hsdrug0130,0,5434758.story
HSL12618
Hensley S.
Vytorin: Who Knew What When at Schering
The Wall Street Journal 2008 Jan 28
http://blogs.wsj.com/health/2008/01/28/vytorin-who-knew-what-when-at-schering/?mod=yahoo_hs
HSL12620
Schering-Plough denies Vytorin study cover-up
CNN Money.com 2008 Jan 28
http://money.cnn.com/2008/01/28/news/companies/schering_rise.ap/?postversion=2008012815
HSL12621
Huckman M.
Schering-Plough And ENHANCE: What Did They Know And When?
CNBC 2008 Jan 28
http://www.cnbc.com/id/22883652
HSL12624
Thomaselli R.
Pharma Biz Cops to $5 Billion Drug Problem: Trade Group to Examine Marketing; Admits to Consumer 'Backlash'
Advertising Age 2008 Jan 28
http://adage.com/article?article_id=123366
HSL12646
Perrone M.
Drug industry reconsiders sales tactics
The Associated Press 2008 Jan 28
http://www.businessweek.com/ap/financialnews/D8UF6JNG2.htm
HSL12616
Moss RW.
Zetia Fails Clinical Trial...Why Was it Ever Approved?
Cancer Decisions 2008 Jan 27
www.cancerdecisions.com/012708.html
HSL12619
Taubes G.
What’s Cholesterol Got to Do With It?
The New York Times 2008 Jan 27
http://www.nytimes.com/2008/01/27/opinion/27taubes.html?ref=health
HSL12626
Lilly speaks out on New York Times article
PM Live 2008 Jan 27
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=6443
HSL12701
Fisher JP.
Future M.D. says no to handouts of drugmakers
News Observer 2008 Jan 27
http://www.newsobserver.com/news/story/905519.html
HSL12570
Groves T.
Mandatory disclosure of trial results for drugs and devices.
BMJ 2008 Jan 26; 336:(7637):170
http://www.bmj.com/cgi/content/full/336/7637/170
HSL12572
Davies PG.
The interpretation of evidence.
BMJ 2008 Jan 26; 336:(7637):174
http://www.bmj.com/cgi/content/full/336/7637/174-a
HSL12573
Williams NR.
Not necessarily.
BMJ 2008 Jan 26; 336:(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-b?etoc
HSL12574
Kendrick M.
Not treating, delaying.
BMJ 2008 Jan 26; 336:(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-d?etoc
HSL12575
Lewis LS.
Pills in the sky.
BMJ 2008 Jan 26; 336:(7637):174
http://www.bmj.com/cgi/content/extract/336/7637/174-e?etoc
HSL12576
Lenzer J.
US Congress and European Research Council insist on open access to research results.
BMJ 2008 Jan 26; 336:(7637):176-7
http://www.bmj.com/cgi/content/extract/336/7637/176?etoc
HSL12577
Lenzer J.
Unreported cholesterol drug data released by company.
BMJ 2008 Jan 26; 336:(7637):180-1
http://www.bmj.com/cgi/content/extract/336/7637/180-a?etoc
HSL12578
Tonks A.
Safer by design.
BMJ 2008 Jan 26; 336:(7637):186-8
http://www.bmj.com/cgi/content/extract/336/7637/186?etoc
HSL12580
Silverman E.
NY AG Subpoenas Merck And Schering-Plough
Pharmalot 2008 Jan 26
http://www.pharmalot.com/2008/01/ny-attorney-general-subpoenas-merck-schering-plough/#more-11507
HSL12656
Cresswell A.
Deloitte appointed to monitor drug company freebies
The Australian 2008 Jan 26
http://www.theaustralian.news.com.au/story/0,25197,23110350-23289,00.html
HSL12564
Merck, Schering speak out on Vytorin flap
CNN Money.com 2008 Jan 25
http://money.cnn.com/2008/01/25/news/companies/bc.apfn.schering.plough.merck.ap/index.htm?source=yahoo_quote
HSL12565
Herper M.
Vytorin's Missing Fail-Safes
Forbes 2008 Jan 25
http://www.forbes.com/2008/01/24/schering-merck-vytorin-biz-healthcare-cx_mh_0125vytorin.html?partner=yahootix
HSL12566
A Wilde-Mathews, Winslow B.
FDA Procedures Draw Scrutiny
The Wall Street Journal 2008 Jan 25
http://online.wsj.com/article/SB120122452254515507.html?mod=googlenews_wsj
HSL12568
MEP says Member States must not "nanny" patients
APM Health Europe 2008 Jan 25
http://www.apmhealtheurope.com/nostory.php?mots=OTC+medicine+producers+should+stop+%27talking+down%27+to+consumers+&numero=10064&ctx=6b4d0ffb3f02a1f58da875d3c9f2e022
HSL12569
FDA Will Wait for Trial Results on Vytorin
The Atlanta Journal-Consitution 2008 Jan 25
http://www.ajc.com/health/content/shared-auto/healthnews/chod/612082.html
HSL12610
Carlat D.
Hired Gun, MD: The Three Million Dollar Man
The Carlat Psychiatry Blog 2008 Jan 25
http://carlatpsychiatry.blogspot.com/2008/01/hired-gun-md-three-million-dollar-man.html
Page 40 of 144 pages ‹ First < 38 39 40 41 42 > Last ›
